| 1 Tag | +1.70% |
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Marc Dunoyer
CEO | Vorstandsvorsitzender | 73 | - |
Sean Christie
DFI | Finanzdirektor/CFO | 53 | 01.08.2021 |
Doyle Shane
COO | Geschäftsführer | - | - |
| Datum | Initiiert | Typ | Hauptposition | Anzahl | % Marktkap. | |
|---|---|---|---|---|---|---|
| 21.07.21 | Emittentenverkauf | Chief Operating Officer (COO) | 172’582 | 0.0781% | ||
| 21.07.21 | Emittentenverkauf | EVP, Chief Compliance Officer | 141’240 | 0.0639% | ||
| 21.07.21 | Emittentenverkauf | Director | 12’840 | 0.0058% |
| % | % 5 Tage | % 1 Jahr | Veränd. 3 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|
| +1.70% | -2.20% | - | - | 40.34 Mrd. | ||
| +0.26% | +4.31% | +48.04% | +162.94% | 1’067 Mrd. | ||
| +1.62% | +7.52% | +60.95% | +54.03% | 635 Mrd. | ||
| +0.37% | +2.55% | +37.84% | +74.57% | 458 Mrd. | ||
| +1.41% | +8.56% | +38.18% | +32.17% | 347 Mrd. | ||
| +1.28% | +4.40% | +37.69% | +41.62% | 295 Mrd. | ||
| +1.72% | +4.10% | +19.44% | +20.45% | 262 Mrd. | ||
| +1.84% | -0.46% | -27.63% | -38.65% | 216 Mrd. | ||
| +0.58% | +3.77% | +25.43% | +60.10% | 203 Mrd. | ||
| +1.93% | -1.42% | +16.18% | +71.64% | 161 Mrd. | ||
| Durchschnitt | +1.40% | +1.33% | +28.46% | +53.21% | 404.83 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +1.11% | +1.95% | +38.02% | +78.61% |
Beschäftigte
3’837
Sektor
Pharmazeutika
















